Researcher Database | Faculty of Pharmaceutical Sciences Department of Pharmacy | Koichi Ohtaki |

（Last updated : 2025-05-21 16:50:37）

Visruth.jpg not found

Koichi Ohtaki

Department / Course Hokkaido University of Science Faculty of Pharmaceutical Sciences Department of Pharmacy

Job Associate Professor

Academic background
2004/09 Degree Acquisition

Present specialized field
Clinical pharmacy

Belonging society
2023/08/30 ～	Japanese Society of Formulary

Book and thesis
Papers	Comparative Study of Information Leaflets for Capecitabine-containing Oral Anticancer Preparations 医薬品相互作用研究 (Co-authored) 2025
Papers	The Relationship Between Efficacy and Safety of Osimertinib Blood Concentration in Patients With EGFR Mutation-positive Lung Cancer: A Prospective Observational Study In Vivo 37 (6),pp.2669-2677 (Co-authored) 2023/06
Papers	Analysis of Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor-Induced Left Ventricular Dysfunction Journal of Biophysical Chemistry 14,pp.67-78 (Co-authored) 2023/05
Papers	Renin-angiotensin system inhibitors may have an advantage over calcium channel blockers in reducing proteinuria in gastric cancer patients receiving ramucirumab Biomed Rep . 17 (3) (Co-authored) 2022/09
Papers	A Questionnaire Survey for Trends in Oral Antimicrobial Prescription and Relationship with Pharmacists due to　Differences in Recognizing the National Action Plan on Antimicrobial Resistance among Dentists Japanese journal of pharmaceutical health care and sciences,pp.292-301 (Co-authored) 2022/07
Display All（9）

Academic conference presentation
2018/09	Linking Hospital and Community Pharmacy: The value of laboratory values stored in QR code prescription (78th FIP World Congress of Pharmacy and Pharmaceutical Sciences 2018， Glasgow(Scotland))
2015/09	EVALUATION OF PROTOCOL-BASED PHARMACIST PRESCRIPTION ENTRY SUPPORT (PPES) INCOLLABORATION WITH PHYSICIANS (75th The International Pharmaceutical Federation: FIP, Dusseldorf)
2015/05	Effectiveness and Acceptability of Ward Pharmacists' Interventions in Improving Medication Therapies (2015 Forbidden City Pharmacist Forum, Beijing)